Molecular Devices' Q2 Revenues Fall Short As Poor Imaging Sales Temper ’06 Outlook | GenomeWeb
Molecular Devices this week said that total second-quarter revenues fell short of its earlier stated guidance while sales of drug-discovery products declined due primarily to lackluster business in imaging products. The company also said a profit turned to loss in the quarter.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.